Triglyceride Fatty Acid Research Articles

18 Months of Treatment with Triheptanoin in 2 Patients with Long Chain Fatty Acid Oxidation Disorders

Introduction:: Long-chain fatty acid oxidation disorders (LC-FAOD) are inborn errors of metabolism, also identified in newborn screening in Portugal. They interfere with adequate energy utilization, namely by muscles, heart, and liver. Treatment aims to maintain patients in an anabolic state, with increased caloric intake, using carbohydrates and medium-chain fatty acids. Treatment with triheptanoin (THP), a synthetic seven-carbon fatty acid triglyceride compound with an anaplerotic effect that increases energy availability to the cell, has been advocated as an efficacious and safe therapy in LC-FAOD. Methods:: Retrospective revision of clinical records of 2 LC-FAOD patients comparing number, severity and admissions for rhabdomyolysis crises, maximum CK values and weight gain in a period of 18 months before and after treatment with THP. Results/Case Report:: Patient 1 is a 12 year old male with VLCADD, with main manifestation being rhabdomyolysis crises. After he started THP we found a decrease in admissions (6 to 2), less rhabdomyolysis crises treated at home (5 to 3), and lower maximum CK values (72352 U/L to 13.000U/L). He had a large increase in weight - 13kg in 18 months. He was able to start pool exercises with no rhabdomyolysis associated. Patient 2 is an 8 year old male with LCAHDD, with main manifestations being rhabdomyolysis crises and retinopathy. After he started THP we found a decrease in admissions (4 to 1), no rhabdomyolysis crises treated at home, and lower maximum CK values (100.000U/L to 19848 U/L). He also increased his weight - 7kg in 18 months. He plays football in school and swims with no rhabdomyolysis associated. In both patients, no major side effects were observed. Conclusion:: In our patients, we could observe a reduction in the number of admissions, and less severe rhabdomyolysis crises after THP use. The weight gain was significant. There were no major side effects. Despite regarding only two patients, our findings are in line with the latest literature on THP and LC-FAOD, reinforcing the utility of THP as one more tool in the treatment of these disorders with rhabdomyolysis as the main manifestation. The weight increase is an issue to be aware of and to address from the start of the treatment.

Exploring the potentialities of an improved triglyceride 16:1ω5 extraction technique for quantitative estimation of arbuscular mycorrhizal fungi in the rhizosphere of olive trees

A method combining solid-phase extraction (SPE) on silica (Si) and aminopropyl-bonded silica (NH2) columns has been applied for the separation of phospholipids (PL), glycolipids (GL), neutral lipids (NL) and triglyceride fatty acids from the spores of Rhizophagus irregularis DAOM 197198 and in olive rhizosphere with and without arbuscular mycorrhizal (AM) fungi. Chromatography on the Si-column resulted in the separation of NL, GL and PL. Chromatography on the NH2- column led to the separation of TG from NL, previously coeluted on the Si-column. The fatty acid composition of TG of Rhizophagus irregularis spores obtained using this method showed higher amounts of 16:1ω5 (40%). The TGFA 16:1ω5 was present in higher levels in rhizosphere with AM fungi than in rhizosphere without AM fungi. This Si/NH2 method provided a rapid separation of TGFA 16:1ω5, commonly found in living cells, and will be useful to quantify the biomass of AM fungi in soil.

Intron-mediated enhancement of DIACYLGLYCEROL ACYLTRANSFERASE1 expression in energycane promotes a step change for lipid accumulation in vegetative tissues

BackgroundMetabolic engineering for hyperaccumulation of lipids in vegetative tissues is a novel strategy for enhancing energy density and biofuel production from biomass crops. Energycane is a prime feedstock for this approach due to its high biomass production and resilience under marginal conditions. DIACYLGLYCEROL ACYLTRANSFERASE (DGAT) catalyzes the last and only committed step in the biosynthesis of triacylglycerol (TAG) and can be a rate-limiting enzyme for the production of TAG.ResultsIn this study, we explored the effect of intron-mediated enhancement (IME) on the expression of DGAT1 and resulting accumulation of TAG and total fatty acid (TFA) in leaf and stem tissues of energycane. To maximize lipid accumulation these evaluations were carried out by co-expressing the lipogenic transcription factor WRINKLED1 (WRI1) and the TAG protect factor oleosin (OLE1). Including an intron in the codon-optimized TmDGAT1 elevated the accumulation of its transcript in leaves by seven times on average based on 5 transgenic lines for each construct. Plants with WRI1 (W), DGAT1 with intron (Di), and OLE1 (O) expression (WDiO) accumulated TAG up to a 3.85% of leaf dry weight (DW), a 192-fold increase compared to non-modified energycane (WT) and a 3.8-fold increase compared to the highest accumulation under the intron-less gene combination (WDO). This corresponded to TFA accumulation of up to 8.4% of leaf dry weight, a 2.8-fold or 6.1-fold increase compared to WDO or WT, respectively. Co-expression of WDiO resulted in stem accumulations of TAG up to 1.14% of DW or TFA up to 2.08% of DW that exceeded WT by 57-fold or 12-fold and WDO more than twofold, respectively. Constitutive expression of these lipogenic “push pull and protect” factors correlated with biomass reduction.ConclusionsIntron-mediated enhancement (IME) of the expression of DGAT resulted in a step change in lipid accumulation of energycane and confirmed that under our experimental conditions it is rate limiting for lipid accumulation. IME should be applied to other lipogenic factors and metabolic engineering strategies. The findings from this study may be valuable in developing a high biomass feedstock for commercial production of lipids and advanced biofuels.Graphical abstract

The serum lipid profiles in immune thrombocytopenia: Mendelian randomization analysis and a retrospective study

BackgroundImmune thrombocytopenia (ITP) is an autoimmune hemorrhagic disease characterized by increased platelet destruction and impaired thrombopoiesis. The changes in platelet indices depend on the morphology and volume of platelets. Serum lipids have been found to affect platelet formation and activity in certain diseases, thus inducing the corresponding variation of platelet indices.MethodsMendelian randomization (MR) analysis was performed based on databases. The clinical data from 457 ITP patients were retrospectively collected and analyzed, including platelet indices, serum lipids, hemorrhages and therapeutic responses.ResultsMR analysis showed low high-density-lipoprotein-cholesterol (HDL-C), low apolipoprotein A-1, high triglyceride (TG) and high apolipoprotein B (ApoB) caused high platelet distribution width (PDW); high low-density-lipoprotein-cholesterol (LDL-C) increased mean platelet volume (MPV). In ITP, there were positive correlations between platelet count with TG, PDW with HDL-C and ApoB, and plateletcrit with TG and non-esterified fatty acid, and the correlation had gender differences. Bleeding scores were negatively correlated with cholesterol and LDL-C. LDL-C and homocysteine were risk factors for therapeutic responses.ConclusionsSerum lipids, especially cholesterol were tightly correlated with platelet indices, hemorrhage and therapeutic effects in ITP patients. These results provide clinical references for the management of serum lipids, and highlight the necessity to further explore the relationship between lipids and pathogenesis of ITP.Trial registrationNo: NCT05095896, October 14, 2021, retrospectively registered.

Simultaneous deoxygenation and isomerization of fatty acid triglycerides of sunflower oil over Pt/Al2O3-zeolite catalysts

The effect of the zeolite type (SAPO-11, ZSM-22, ZSM-23 and ZSM-12) in the support (the zeolite to Al2О3 ratio of 30 : 70) on physicochemical properties of Pt/Al2О3-zeolite catalysts as well as on the yield and composition of the products of sunflower oil hydrodeoxygenation over these catalysts was studied. The possibility of complete hydrodeoxygenation of sunflower oil at temperatures 320–350 °C, pressure 4 MPa, and mass flow rate 1 h–1 with the yield of liquid products 75–82 % was demonstrated. The fraction of isoalkanes and the yield of products from direct hydrodeoxygenation increase with the concentration of Broensted acid sites in the catalyst in the following series: 1%Pt/Al2O3-ZSM-22 < < 1%Pt/Al2O3-ZSM-12 < 1%Pt/Al2O3-ZSM-23 < 1%Pt/Al2O3-SAPO-11.

Biomarkers for cheese authentication by detailed and fast gas chromatographic profiling of triacylglycerol fatty acids.

Unsaturated fatty acid isomers and odd- and branched-chain fatty acids (OBCFAs) in milk triacylglycerols (TAGs) can be quantitated using gas chromatography (GC), providing access to biomarkers of animal species, breeds, diet, geographic origin, and environmental conditions. Such analysis requires expensive cyanopropyl siloxane or ionic liquid columns of at least 50m in length, which increases the elution time. Aiming to use GC for cheese authentication and characterization while keeping the experiment time short and maintaining a good separation between fatty acid (FA) isomers, we considered using a 30m polyethylene glycol-2-nitroterephthalate column. The FAs thus quantitated allowed the discovery of specific biomarkers for the origins of cheese varieties highly consumed in several countries. In addition, the simple and multivariate correlations we found between FAs in the cheese TAG matrix were alternative means for characterization and authentication purposes.

The Genome of the Korean Island-Originated Perilla citriodora 'Jeju17' Sheds Light on Its Environmental Adaptation and Fatty Acid and Lipid Production Pathways.

Perilla is a key component of Korean food. It contains several plant-specialized metabolites that provide medical benefits. In response to an increased interest in healthy supplement food from the public, people are focusing on the properties of Perilla. Nevertheless, unlike rice and soybeans, there are few studies based on molecular genetics on Perilla, so it is difficult to systematically study the molecular breed. The wild Perilla, Perilla citriodora 'Jeju17', was identified a decade ago on the Korean island of Jeju. Using short-reads, long-reads, and Hi-C, a chromosome-scale genome spanning 676 Mbp, with high contiguity, was assembled. Aligning the 'Jeju17' genome to the 'PC002' Chinese species revealed significant collinearity with respect to the total length. A total of 31,769 coding sequences were predicted, among which 3331 were 'Jeju17'-specific. Gene enrichment of the species-specific gene repertoire highlighted environment adaptation, fatty acid metabolism, and plant-specialized metabolite biosynthesis. Using a homology-based approach, genes involved in fatty acid and lipid triacylglycerol biosynthesis were identified. A total of 22 fatty acid desaturases were found and comprehensively characterized. Expression of the FAD genes in 'Jeju17' was examined at the seed level, and hormone signaling factors were identified. The results showed that the expression of FAD genes in 'Jeju17' at the seed level was high 25 days after flowering, and their responses of hormones and stress were mainly associated with hormone signal transduction and abiotic stress via cis-elements patterns. This study presents a chromosome-level genome assembly of P. citriodora 'Jeju17', the first wild Perilla to be sequenced from the Korean island of Jeju. The analyses provided can be useful in designing ALA-enhanced Perilla genotypes in the future.

Utilisation of mealworm (Tenebrio molitor) oil in Pacific white shrimp (Litopenaeus vannamei) diet

Abstract Mealworm (Tenebrio molitor) and their derivatives are sustainable ingredients in aquaculture feeds. This study evaluated the effect of fish oil (FO) replacement with mealworm oil (MO) on growth performance, non-specific immune responses and disease resistance against Vibrio parahaemolyticus for Pacific white shrimp (Litopenaeus vannamei). FO in a control diet (Con) was replaced with MO at levels of 25%, 50%, 75% and 100% (designated as MO25, MO50, MO75 and MO100, respectively). A total of 480 shrimp (initial mean body weight, 0.884 ± 0.004 g) were randomly distributed into 20 acrylic tanks (240 L) in quadruplicates groups and fed the experimental diets for 58 days. Growth performance was significantly higher in all MO groups than in Con group. Shrimp fed MO50 and MO75 diets showed significantly improved feed utilisation efficiency than shrimp fed Con diet. Lipid metabolism related-gene expressions of fatty acid binding protein and triacylglycerol lipase in hepatopancreas were significantly downregulated by increment of MO in the diets. Digestibility of protein, lipid, energy and dry matter were not significantly affected by the dietary treatments, while digestibility of poly-unsaturated fatty acids (PUFAs) were significantly decreased by dietary MO supplementation. The levels of n-3 PUFA in muscle and hepatopancreas were significantly decreased with increasing MO levels in the diets. Cumulative survival of shrimp in a challenge test against V. parahaemolyticus was higher in all MO groups and significantly higher in MO25 group than in Con group. Non-specific immune responses were significantly enhanced in all MO groups than in Con group. Replacement of FO with MO in the diets significantly increased haemolymph cholesterol and triglyceride levels. Our findings suggest that MO could be utilised as a promising substitute for FO in the diets of L. vannamei and optimal FO replacement level would be 50% for growth and 25% for disease resistance against V. parahaemolyticus.

Effects of dietary dihydromyricetin on growth performance, antioxidant capacity, immune response and intestinal microbiota of shrimp (Litopenaeus vannamei)

A 56-day culture trial was conducted to evaluate the effects of dietary dihydromyricetin (DMY) on growth performance, antioxidant capacity, immune response and intestinal microbiota of shrimp (Litopenaeus vannamei). 840 healthy shrimp (1.60 ± 0.21 g) in total were fed with four different levels of DMY diets at 0 (Control), 100 (D1), 200 (D2), and 300 (D3) mg/kg, respectively. Samples were collected after the culture trial, and then, a 7-day challenge experiment against Vibrio parahaemolyticus was conducted. The results demonstrated that DMY significantly enhanced the activity of protease, amylase and lipase as well as the expression of lipid and protein transport-related genes (P < 0.05). The results of plasma lipid parameters indicated that DMY reduced lipid deposition, manifested by significantly (P < 0.05) decreased plasma total cholesterol (T-CHO), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C). The expression of genes involved in fatty acid β-oxidation and triglyceride catabolism was significantly up-regulated (P < 0.05), and genes involved in triglyceride synthesis were significantly down-regulated in DMY groups when compared to control group (P < 0.05). Moreover, dietary DMY also significantly (P < 0.05) increased the total antioxidant capacity (T-AOC), antioxidant enzymes activity and glutathione (GSH) content of shrimp, and a significant increase of total hemocytes count (THC), phagocytic rate (PR), antibacterial activity (AA) and bacteriolytic activity (BA) was observed in DMY groups (P < 0.05). The addition of DMY to the diet significantly augmented immune response by up-regulating the expression of genes related to toll-like receptors (Toll) signaling pathway, immune deficiency (IMD) signaling pathway and intestinal mucin. Furthermore, dietary DMY could modulate the composition and abundance of intestinal microbiota. In conclusion, DMY showed promising potential as a functional feed additive for shrimp to improve the growth performance and physiological health.

Effects of branched‐chain fatty acid triacylglycerols on the crystallization of palm oil‐based blends

AbstractThe aim of this study was to assess how branched‐chain fatty acid triacylglycerols (BCFA‐TAG) at different concentrations (1–10 g/100 g) affect palm oil‐based blend PO‐PS (palm olein/palm stearin = 7/3, wt/wt) crystallization and other related performance. The addition of BCFA‐TAG significantly affected the crystallization of PO‐PS by accelerating the onset of PO‐PS crystallization through promoting the nucleation of PO‐PS crystals while delaying the growth of the crystals as a whole. The reduction in t1/2 provided good evidence of the delay, with the effect of high concentrations (10 g/100 g) being the most pronounced. Adding BCFA‐TAG to PO‐PS reduced its solid fat content (SFC), with a more significant effect at higher concentrations (5, 8, and 10 g/100 g). After 48 h of crystallization at 25°C, BCFA‐TAG induced a more compact and orderly crystalline network of PO‐PS with an increase in space‐filling, resulting in an increase in hardness. The crystal density of the higher concentration samples (PO‐PS + 10% BCFA‐TAG) decreased over storage time, suggesting a crystal dilution effect of high concentrations of BCFA‐TAG. The PO‐PS + 10% BCFA‐TAG sample maintained the β′ crystalline form throughout the 30 days of storage without conversion to the β crystalline form, thus showing a positive effect of BCFA‐TAG in alleviating the post‐hardness of the palm oil.

Cheong-sang-bang-pung-san alleviated hepatic lipid accumulation by regulating lipid metabolism in vitro and in vivo.

Introduction: The occurrence of fatty liver disease, resulting from the accumulation of excessive fat within the liver, has been showing a significant and rapid increase. This study aimed to evaluate the therapeutic effects of Cheong-sang-bang-pung-san extract (CB) on fatty liver disease, and to elucidate the underlying mechanisms. Methods: We used a high-fat diet (HFD)-fed fatty liver mice and free fatty acid (FFA) induced HepG2 cell lipid accumulation model. The levels of serum, hepatic, and intracellular lipid content were assessed. Histopathological staining was used to evaluate the extent of hepatic lipid accumulation. Real-time polymerase chain reaction and Western blotting were conducted to examine the expression of factors associated with lipid metabolism. Results: We demonstrated that treatment with CB dramatically reduced body weight, liver weight, and fat mass, and improved the serum and hepatic lipid profiles in HFD-induced fatty liver mice. Additionally, CB alleviated lipid accumulation in HFD-fed mice by controlling lipid metabolism, including fatty acid uptake, triglyceride and cholesterol synthesis, and fatty acid oxidation, at the mRNA as well as protein levels. In free fatty acid-treated HepG2 cells, CB significantly reduced intracellular lipid accumulation by regulating lipid metabolism via the activation of AMP-activated protein kinase. Conclusion: These findings provide insights into the mechanisms underlying CB's effects on liver steatosis and position of CB as a potential therapeutic candidate for managing lipid metabolic disorders.

Effects of dietary crude polysaccharides from Lycium barbarum on growth performance, digestion, and serum physiology and biochemistry of spotted sea bass Lateolabrax maculatus

High-quality development requires the aquaculture industry to reduce the use of chemicals and further improve feed efficiency, while the use of Lycium barbarum polysaccharide (LBP) is one of a potential way to achieve it. The current study was conducted to investigate the effects of dietary LBP on growth performance, digestion, antioxidant capacity, hepatic and intestinal morphology, and serum lipids of spotted sea bass, Lateolabrax maculatus. A total of 450 spotted sea bass (20.64 ± 0.18) g were assigned to 18 tanks. Three tanks were defined as a group, and fish in each group were given diets with increasing level of LBP (0, 0.25, 0.50, 0.75, 1.00 and 1.25 g/kg) for 49 days, respectively. Results showed that dietary intake of LBP significantly improved the weight gain, specific growth rate, feed conversion ratio, amylase activity and lipase activity of spotted sea bass. However, no significant effect of LBP on fish superoxide dismutase, malondialdehyde and catalase was observed. Dietary LBP alleviated ballooning degeneration and fat vacuoles in fish liver. However, mild inflammation was observed in 1 g/kg LBP group fish liver. Dietary LBP significantly increased the high-density lipoprotein cholesterol level of fish, and reduced the total cholesterol and low-density lipoprotein cholesterol level. The expression of hepatic FAS and SREBP-1 were significantly down-regulate, and the expression of PPAR-α, CPT1, HSL, ATGL and LPL were significantly up-regulated by dietary LBP. This result reminder that dietary LBP may inhabit the synthesis of fatty acid, and promote the fatty acid oxidization and triglycerides hydrolyzation. In conclusion, dietary LBP improved growth performance, digestion, hepatic morphology, and serum biochemical parameters of spotted sea bass in size (20.64 ± 0.18) g. The optimal addition of LBP for spotted sea bass is about 1 g/kg based on the regression analysis.

Methionine supplemented in a high fat-diet: Effects of growth performance and lipid metabolism in rice field eel (Monopterus albus)

An eight-week feeding trial explored the mechanism of methionine supplementation (0 g/kg, 4 g/kg, 8 g/kg, 12 g/kg) in a high-fat diet (120 g/kg fat, HFD) on the growth performance and hepatic lipid metabolism of M. albus (initial weight 25.03 ± 0.13 g) based on a basic diet (60 g/kg fat), named as Con, HFD+M0, HFD+M4, HFD+M8, HFD+M12, respectively. 1) Compared with Con, high-fat diet decreased the survival rate and weight gain rate of M. albus, and significantly enhanced the feed conversion rate, hepatopancreas index and crude lipid content of M. albus (P < 0.05). Compared with HFD + M0, supplemented methionine markedly enhanced weight gain rate of M. albus (P < 0.05), and significantly decreased feed conversion rate and crude lipid content of M. albus (P < 0.05). 2) Compared with Con, hepatic lipoprotein lipase, fatty acid synthetase, triglyceride, cholesterol and fatty acid (C18:2n6, C20:5n3, SFA and MUFA) of HFD + M0 were markedly improved (P < 0.05); compared with HFD + M0, hepatic fatty acid synthase, triglyceride, cholesterol and fatty acid (C18:0, SFA and n-6PUFA) of HFD + M8 were significantly decreased (P < 0.05). Additionally, the proportion of hepatic vacuoles of HFD + M0 was higher than that in Con; compared with HFD + M0, hepatic cells of HFD + M8 were more regularly, and the proportion of hepatic vacuoles and lipid droplets decreased. 3) Compared with Con, hepatic srebf2, hsl, lpl, srebf1, cpt1 and cpt2 were remarkably up-regulated in HFD+M0 (P < 0.05); compared with HFD+M0, hepatic gcn2, eif2a, srebf2, srebf1 and fas were remarkably down-regulated in HFD+M8 (P < 0.05). Additionally, compared with HFD + M0, SREBP1 protein expression of HFD + M8 were markedly down-regulated (P < 0.01). In conclusion, dietary methionine mainly reduced hepatic lipid abnormal deposition by reducing hepatic fatty acid synthesis.

Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade.

Intravascular hemolysis is a common feature of different clinical entities, including sickle cell disease and malaria. Chronic hemolytic disorders are associated with hepatic damage; however, it is unknown whether heme disturbs lipid metabolism and promotes liver steatosis, thereby favoring the progression to nonalcoholic fatty liver disease (NAFLD). Using an experimental model of acute intravascular hemolysis, we report here the presence of liver injury in association with microvesicular lipid droplet deposition. Hemolysis promoted serum hyperlipidemia and altered intrahepatic triglyceride fatty acid composition, with increments in oleic, palmitoleic, and palmitic acids. These findings were related to augmented expression of transporters involved in fatty acid uptake (CD36 and MSR1) and deregulation of LDL transport, as demonstrated by decreased levels of LDL receptor and increased PCSK9 expression. Hemolysis also upregulated hepatic enzymes associated with cholesterol biosynthesis (SREBP2, HMGC1, LCAT, SOAT1) and transcription factors regulating lipid metabolism (SREBP1). Increased LC3II/LC3I ratio and p62/SQSTM1 protein levels were reported in mice with intravascular hemolysis and hepatocytes stimulated with heme, indicating a blockade of lipophagy. In cultured hepatocytes, cell pretreatment with the autophagy inductor rapamycin diminished heme-mediated toxicity and accumulation of lipid droplets. In conclusion, intravascular hemolysis enhances liver damage by exacerbating lipid accumulation and blocking the lipophagy pathway, thereby promoting NAFLD. These new findings have a high translational potential as a novel NAFLD-promoting mechanism in individuals suffering from severe hemolysis episodes. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

The Effect of Nanoadditives in Natural Ester Dielectric Liquids: A Comprehensive Review on Stability and Thermal Properties

Numerous experimental investigations were carried out by several researchers exploring vegetable oils as substitutes for transformer oil, since these vegetable oils are biodegradable. Also, their usage may reduce the negative environmental impact of other traditional oils. Additionally, since today’s mineral oils are made from petroleum-based materials, they will ultimately run out in the near future. Vegetable oils might therefore be a contender to take the place of mineral oils in transformer applications. Vegetable oils are natural esters and are triglycerides of fatty acids that can be extracted from a wide variety of plants. Natural esters are more cost-effective than synthetic esters and they also abundant in many countries. This paper provides a comprehensive review on natural esters-based nanofluids. First, the necessity, benefits, and drawbacks of natural esters are all discussed. Methods used to improve the effectiveness of natural esters and overcome their disadvantages are presented. Then, the concept of nanofluids is introduced, and recent experimental research on dielectric nanofluids is reviewed in details, including preparation methodology, stability inspection, and thermal properties. Finally, all physical mechanisms behind the obtained results are discussed and clarified.

Plasma lipid metabolites as potential biomarkers for identifying individuals at risk of obesity-induced metabolic complications

Lipidomics studies have indicated an association between obesity and lipid metabolism dysfunction. This study aimed to evaluate and compare cardiometabolic risk factors, and the lipidomic profile in adults and older people. A cross-sectional study was conducted with 72 individuals, divided into two sex and age-matched groups: obese (body mass index—BMI ≥ 30 kg/m2; n = 36) and non-obese (BMI < 30 kg/m2; n = 36). The lipidomic profiles were evaluated in plasma using 1H nuclear magnetic resonance (1H-NMR) spectroscopy. Obese individuals had higher waist circumference (p < 0.001), visceral adiposity index (p = 0.029), homeostatic model assessment insulin resistance (HOMA-IR) (p = 0.010), and triacylglycerols (TAG) levels (p = 0.018). 1H-NMR analysis identified higher amounts of saturated lipid metabolite fragments, lower levels of unsaturated lipids, and some phosphatidylcholine species in the obese group. Two powerful machine learning (ML) models—k-nearest neighbors (kNN) and XGBoost (XGB) were employed to characterize the lipidomic profile of obese individuals. The results revealed metabolic alterations associated with obesity in the NMR signals. The models achieved high accuracy of 86% and 81%, respectively. The feature importance analysis identified signal at 1.50–1.60 ppm (–CO–CH2–CH2–, Cholesterol and fatty acid in TAG, Phospholipids) to have the highest importance in the two models.

Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice.

Combined glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP1R) agonism is superior to single GLP1R agonism with respect to glycemic control and weight loss in obese patients with or without type 2 diabetes. As insulin resistance and obesity are strong risk factors for nonalcoholic fatty liver disease (NAFLD), in the current study we investigated the effects of combined GIPR/GLP1R agonism on NAFLD development. Male APOE∗3-Leiden.CETP mice, a humanized model for diabetic dyslipidemia and NAFLD when fed a high-fat high-cholesterol diet, received subcutaneous injections with either vehicle, a GIPR agonist, a GLP1R agonist, or both agonists combined every other day. GIPR and GLP1R agonism reduced body weight and additively lowered fasting plasma levels of glucose, triglycerides and total cholesterol. Strikingly, we report an additive reduction in hepatic steatosis as evidenced by lower hepatic lipid content and NAFLD scores. Underlying the lipid-lowering effects were a reduced food intake and intestinal lipid absorption and an increased uptake of glucose and triglyceride-derived fatty acids by energy-combusting brown adipose tissue. Combined GIPR/GLP1R agonism also attenuated hepatic inflammation as evidenced by a decreased number of monocyte-derived Kupffer cells and a reduced expression of inflammatory markers. Together, the reduced hepatic steatosis and inflammation coincided with lowered markers of liver injury. We interpretate that GIPR and GLP1R agonism additively attenuate hepatic steatosis, lower hepatic inflammation, ameliorate liver injury, together preventing NAFLD development in humanized APOE∗3-Leiden.CETP mice. We anticipate that combined GIPR/GLP1R agonism is a promising strategy to attenuate NAFLD progression in humans. This work was supported by a grant from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development, and the Royal Netherlands Academy of Sciences [CVON-GENIUS-II] to P.C.N.R., a Lilly Research Award Program [LRAP] Award to P.C.N.R. and S.K., a Dutch Heart Foundation [2017T016] grant to S.K., and an NWO-VENI grant [09150161910073] to M.R.B.; J.F.D.B. is supported by the Nutrition and Health initiative of the University of Groningen; Z.Y. is supported by a full-time PhD scholarship from the China Scholarship Council (201806850094 to Z.Y.).

EFFECT OF GRAPE SEED OIL FORTIFICATION WITH EXTRACTS OF NATURAL ANTIOXIDANTS

Grape seed oil (GSO) consists mostly of triglycerides of polyunsaturated fatty acids, which are sensitive to oxidation and to the high temperatures. The aim of this research was to study the effect of GSO fortification with hydroalcoholic extracts of antioxidants from grape seeds, up to and after 12 months. It was established that the immediate effect of the oil fortification was the increase of the total polyphenol content (TPC) in the oil, by up to 141.34 mg GAE/kg of oil, and the increase of the DPPH• antioxidant activity by up to 0.580 mmol TE/kg (in the control sample, refined grape oil, these values were 1.57 mg GAE/kg and 0.003 mmol TE/kg, respectively). After 12 months, TPC and DPPH• antioxidant activity decreased nearly 10-fold in all of the fortified oil samples. The difference between the oxidative status of the oil was assessed (UV-Vis). In the case of the GSO sample, treated with n-octyl gallate, the absorbances remained unchanged after 12 months. When compared to the synthetic antioxidant n-octyl gallate, grape seed polyphenolic extracts were found to have a less protective effect on the oil during storage under environmental conditions.

Cytokine storm associated with severe COVID-19 infections: The potential mitigating role of omega-3 fatty acid triglycerides in the ICU.

Cytokine storm during severe COVID-19 infection increases the risk of mortality in critically ill patients in the intensive care unit. Multiple therapeutic proposals include, for example, anti-inflammatory and immunosuppressive agents, selective inhibitors of key pro-inflammatory receptors, and key enzymes necessary for viral replication. Unfortunately, safe and effective therapy remains an elusive goal. An alternative anti-inflammatory approach vis á vis omega-3 fatty acids, which yields less pro-inflammatory mediators by altering eicosanoid metabolism, has been proposed. Although theoretically promising, enteral tube delivery or oral capsules containing specific doses of omega-3 fatty acids take precious time (7 days to 6 weeks) to be incorporated in plasma cell membranes to be most effective, making this route of administration in the acute care setting an unfeasible therapeutic approach. Parenteral administration of precise doses of omega-3 fatty acid triglycerides in an injectable emulsion can greatly accelerate the incorporation and potential therapeutic effects (within hours), but at present, there is no commercially available product designed for this purpose. We describe a potential formulation that may address this deficiency, while recognizing that the high incidence of hyperlipidemia that occurs during severe COVID-19 infection must be recognized as a complicating factor, and, therefore, caution is advised.

Development of a novel dual-enzyme screen-printed amperometric biosensor for the analysis of esterified fatty acids

This paper describes, for the first time, the development of a novel trilinolein biosensor based on the immobilisation of lipase and lipoxygenase (LOX) onto a cobalt phthalocyanine screen-printed carbon electrode (CoPC-SPCE) in conjunction with amperometry in stirred solution. The combination of enzymes, integrated into the novel biosensor, provide a selective response for polyunsaturated fatty acid (PUFA) triglycerides, in the presence of both monounsaturated (MUFA) and saturated fatty acid (SFA) triglycerides. The linear range of the trilinolein biosensor is 0.2–10 µM, and the detection limit is 45.5 nM. The biosensor was successfully applied to the measurement of trilinolein present in a pharmaceutical food supplement. The percentage recovery was 86% and the coefficient of variation of the biosensor response was 5.05%. This novel LOX-lipase biosensor is simple to manufacture for trilinolein analysis and has advantages of low cost, speed of analysis and ease of operation, thus making it commercially attractive for a range of applications including food and clinical samples.